LIMINATUS PHARMA, INC.
Last · —$3.25-0.16 (-4.69%)live · yahoo · 2s ago
Vol 20.1K ≈ 65.3K
MA10MA20MA50
Market cap$4.37M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameLIMINATUS PHARMA, INC.
HQUnited States (US)
ListingUS LIMN
ISINUS53271X1081
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2836
CurrencyUSD
Entity registrysec:0001971387
CIK0001971387
Websiteliminatuspharma.com
Employees1
Loading chart…
Press & signals
- GlobeNewswire
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
- GlobeNewswire
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
- GlobeNewswire
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline
Documents
FormReporting forFiledFlags
Showing 5 of 10 filings